The Chinese medicine Fufang Zhenzhu Tiaozhi capsule protects against atherosclerosis by suppressing EndMT via modulating Akt1/β-catenin signaling pathway
Bibliographic Data
FTZ delayed atherosclerosis by inhibiting EndMT via the Akt1/β-catenin pathway
AKT1 · Angiogenesis · Biology · Blot · CD31 · Cholesterol · Diabetes mellitus · Downregulation and upregulation · Dyslipidemia · Endothelial Dysfunction · Gene · In vitro · Internalization · Lipoprotein · Mesenchymal stem cell · Protein kinase B · Receptor · Signal transduction · Transfection · Umbilical vein · Cancer-related molecular mechanisms research · Chemistry · Kruppel-like factors research · Lipid metabolism and disorders · Medicine · Biochemistry · Cancer Research · Cell Biology · Endocrinology · Internal Medicine
Chinese herbal medicine and risk of coronary heart disease in patients with hyperlipidemia
Withdrawn
Heshuxiaoji pill suppresses steatohepatitis and fibrosis by regulating the AngII-Bach1 mediated vasoconstriction
Fufang Zhenzhu Tiaozhi (FTZ) capsule ameliorates diabetes-accelerated atherosclerosis via suppressing YTHDF2-mediated m6A modification of Sirt3 mRNA
ZiBuPiYin recipe ameliorates diabetes-associated cognitive decline by improving neuronal mitochondrial function in chronic psychologically stressed zucker diabetic fatty rats
Fufang Zhenzhu Tiaozhi (FTZ) suppression of macrophage pyroptosis
| Unique citing works | 6 |
|---|---|
| Citations per year | 2 |
| Citation span | 2023 - 2026 (4) |
| Citation velocity | current |
| Highly cited | No |
| Citation types | Neutral: 6 |